Featured Story TAVR at Johns Hopkins
Originally intended for high-risk patients, TAVR is now being offered to low-risk ones as part of a national clinical trial that includes Johns Hopkins.
Originally intended for high-risk patients, TAVR is now being offered to low-risk ones as part of a national clinical trial that includes Johns Hopkins.
Patients dealing with rare anomalies of the peripheral vascular system can now turn to a database linking patients to physicians to help relieve complications.
A treatment normally reserved for patients with stubbornly high low-density lipoprotein (LDL) cholesterol offers promise to reduce inflammation after heart attacks.
Meet five new experts with specialized cardiovascular skills and diverse research interests.
Specialists work together to review concerns as the machine allows critically ill patients their best chance to recover function.